GRP
MRTX

Global Retirement Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Global Retirement Partners’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25
Closed -$1.48K – 3513
2023
Q4 		$1.48K Buy
25
+5
+25% +$281 ﹤0.01% 2781
2023
Q3 		$858 Sell
20
-19
-49% -$678 ﹤0.01% 2808
2023
Q2 		$1.41K Buy
39
+8
+26% +$330 ﹤0.01% 2668
2023
Q1 		$1.4K Buy
31
+26
+520% +$1.17K ﹤0.01% 2623
2022
Q4 		$227 Sell
5
-107
-96% -$6.92K ﹤0.01% 2933
2022
Q3 		$8K Sell
112
-4
-3% -$296 ﹤0.01% 1787
2022
Q2 		$8K Buy
116
+14
+14% +$890 ﹤0.01% 1753
2022
Q1 		$6K Buy
+102
New +$10.4K ﹤0.01% 1852
2021
Q4 		– Sell
-44
Closed -$8K – 1934
2021
Q3 		$8K Buy
+44
New +$7.08K ﹤0.01% 1500

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Global Retirement Partners's MRTX Position: Q1 2024 in Review

Global Retirement Partners sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 25 shares — an estimated $1.48K sold.

Global Retirement Partners first reported a position in MRTX in Q3 2021 and held it in 9 quarters. The position peaked at $8K in Q3 2022. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Global Retirement Partners reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Global Retirement Partners sold 25 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.48K.
  • Global Retirement Partners first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Global Retirement Partners's Mirati Therapeutics, Inc. Common Stock position peaked at $8K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Global Retirement Partners's 13F filing for Q1 2024, filed 23 Apr 2024.